Literature DB >> 17205149

The role of cytokines in non-alcoholic steatohepatitis. A review.

Ionel Copaci1, Laurentiu Micu, Mihai Voiculescu.   

Abstract

The pathogenesis of NASH is being unraveled by studies of animal models and humans with this disorder. The necro-inflammatory component of NASH appears to be modulated by interactions among various factors (for example cytokines, hormones, neurotransmitters) that regulate the biological activity of TNF- and other proinflammatory (Th-1) cytokines. Hepatic necroinflammation is necessary, but not sufficient, for progression to cirrhosis. Factors such as leptin inducible factors (for example, noradrenaline), that regulate the activity of profibrogenic cytokines, such as IL-10 and TGF-beta, dictate the extent of fibrosis that occurs during liver injury. A better understanding of how these and other soluble and cell associated factors regulate the phenotypes of different types of liver cells should help us to develop rationale treatments for NASH and other disorders in the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17205149

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  27 in total

1.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

Review 2.  Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation.

Authors:  Amit D Tevar; Calissia Clarke; Jiang Wang; Steven M Rudich; E Steve Woodle; Alex B Lentsch; Michael L Edwards
Journal:  J Am Coll Surg       Date:  2010-04       Impact factor: 6.113

Review 3.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 4.  Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.

Authors:  Kareem Hassan; Varun Bhalla; Mohammed Ezz El Regal; H Hesham A-Kader
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice.

Authors:  Ratanesh Kumar Seth; Suvarthi Das; Sahar Pourhoseini; Diptadip Dattaroy; Stephen Igwe; Julie Basu Ray; Daping Fan; Gregory A Michelotti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  J Pharmacol Exp Ther       Date:  2014-10-27       Impact factor: 4.030

6.  Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice.

Authors:  Anil K Agarwal; Suja Sukumaran; Víctor A Cortés; Katie Tunison; Dario Mizrachi; Shireesha Sankella; Robert D Gerard; Jay D Horton; Abhimanyu Garg
Journal:  J Biol Chem       Date:  2011-08-27       Impact factor: 5.157

7.  Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.

Authors:  Diptadip Dattaroy; Sahar Pourhoseini; Suvarthi Das; Firas Alhasson; Ratanesh Kumar Seth; Mitzi Nagarkatti; Gregory A Michelotti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-11       Impact factor: 4.052

8.  TNF-{alpha} plays a role in hepatocyte apoptosis in Niemann-Pick type C liver disease.

Authors:  Victoria M Rimkunas; Mark J Graham; Rosanne M Crooke; Laura Liscum
Journal:  J Lipid Res       Date:  2008-09-24       Impact factor: 5.922

9.  A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin.

Authors:  Jun-Fen Fu; Yan-Lan Fang; Li Liang; Chun-Lin Wang; Fang Hong; Guan-Ping Dong
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

10.  Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice.

Authors:  Ratanesh Kumar Seth; Ashutosh Kumar; Suvarthi Das; Maria B Kadiiska; Gregory Michelotti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Toxicol Sci       Date:  2013-05-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.